Evidence map›Paper›PMID 40114595›Full record

ArticleFuture medicinal chemistry2025

Synergistic anti-inflammatory and anti-tb effects of Au-Pt-Cu nanofluids: experimental and computational insights.

Amit Dubey, Manish Kumar, Amer M Alanazi, Aisha Tufail, Abhay D Bagul

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Vitamin BRSC advances · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amit DubeyCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India.ORCID 0000-0003-0737-0488
Manish KumarDepartment of Biochemistry, Iswar Saran Degree College, University of Allahabad (A Constituent PG College of University of Allahabad), Prayagraj, India.
Amer M AlanaziPharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Aisha TufailComputational Chemistry and Drug Discovery Division, Quanta Calculus, Greater Noida, India.ORCID 0000-0001-7349-9162
Abhay D BagulDepartment of Chemistry, Vasantrao Naik Mahavidhyalaya, Aurangabad, India.ORCID 0000-0003-0315-7508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo explore the potent anti-inflammatory and anti-tuberculosis potential of novel trimetallic Au-Pt-Cu nanofluids. MATERIALS &

methodsWe employed BSA assay for anti-inflammatory assessment and tested anti-tuberculosis activity against

resultsThe nanofluids demonstrated impressive IC

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntitubercular AgentsCopperGoldMetal NanoparticlesMycobacterium tuberculosisAnimalsDensity Functional TheoryHumansMicrobial Sensitivity TestsMolecular Docking SimulationMolecular Dynamics SimulationAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntitubercular AgentsCopperGoldADMET profilesanti-inflammatoryAnti-tuberculosisdiclofenac sodiummolecular dockingmolecular dynamics simulationstherapeutic agentstrimetallic nanofluids

Identifiers

PMID40114595
PMCPMC11938965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.